Skip to main content
. 2022 Jun 20;11(12):3554. doi: 10.3390/jcm11123554

Table 1.

Inclusion/exclusion criteria and cardiovascular risk factors targets.

Inclusion Criteria Exclusion Criteria
  • Consecutive adult patients with stable IHD and/or PAD:
    • Stable IHD was defined as follows:
      • (1) The history of previous myocardial infarction, or
      • (2) Diagnosis of multivessel coronary disease with two major epicardial arteries having >50% stenosis, with symptoms or history of stable or unstable angina, or
      • (3) Multivessel coronary disease revascularization, either percutaneous or surgical, within 1 to 10 years before inclusion.
      • (4) In addition, patients should be ≥65 years or <65 years with revascularization of ≥2 major epicardial arteries, or with ≥2 additional risk factors (i.e., smoking, diabetes, eGFR < 60 mL/min/1.73 m2, heart failure or nonlacunar ischemic stroke).
    • PAD was defined as:
      • (1) Any revascularization of lower extremities, or
      • (2) Previous vascular amputation of any part of lower extremities, or
      • (3) Arterial stenosis ≥50%, or
      • (4) History of intermittent claudication, or
      • (5) An ankle–brachial index <0.9, or
      • (6) Patients with carotid disease, including previous revascularization or arterial stenosis ≥50%.
  • Patients should provide written informed consent

  • Patients hospitalized at inclusion

  • Patients with a history of atrial fibrillation or other indication for anticoagulation

Cardiovascular risk factors targets
Blood pressure [17]
  • <140/90 mmHg

  • <130/80 mmHg

  • <120/70 mmHg

Lipids [18,19]
  • LDL cholesterol < 70 mg/dL

  • LDL cholesterol < 55 mg/dL

Diabetes [20]
  • HbA1c < 7% and treatment with SGLT2i or GLP1-RA

  • HbA1c < 6.5% and treatment with SGLT2i or GLP1-RA

eGFR: estimated glomerular filtration rate; SGLT2i: sodium-glucose cotransporter-2 inhibitors; GLP1-RA: glucagon-like peptide 1 receptor agonists.